Adjustable gastric banding more effective when combined with gastrointestinal hormone GLP-1

June 20, 2013

Pharmacological activation of the receptor for glucagon-like peptide 1 (GLP-1) in conjunction with adjustable gastric banding (AGB) surgery may improve weight loss outcomes achieved with this procedure when compared to performing AGB alone, say researchers from the University of Cincinnati (UC) and the Helmholtz Center in Munich, Germany.

These findings, the authors say, "suggest an opportunity to optimize bariatric surgery with adjunctive pharmacotherapy."

The , which appears June 17, 2013, online ahead of print in the journal Diabetes, was led by Kirk Habegger, PhD, research assistant professor in the endocrinology, diabetes and metabolism division at UC, and Matthias Tschöp, MD, adjunct professor at UC and director of the Institute for Diabetes and Obesity at the Helmholtz Center.

"To our knowledge, these are the first findings to show that pharmacological therapies can augment and improve in the treatment of obesity," says Habegger, a researcher with UC's Metabolic Diseases Institute.

GLP-1 is an incretin—a gastrointestinal hormone causing an increased release of insulin after eating to combat the onset of elevated . GLP-1 has been used in the development of existing .

A 2011 study led by UC Marzieh Salehi, MD, linked the immediate improvements in blood sugar in humans following gastric bypass surgery to the increased secretion of GLP-1 that occurs in these patients. Because administration of GLP-1-based drugs alone has been linked to weight loss, scientists believe that GLP-1 secretion post gastric bypass could explain the successful and sustained weight loss experienced by many patients.

Unlike gastric bypass surgery, however, less-invasive adjustable gastric banding does not trigger increased GLP-1 secretion, and has been shown to be less effective in promoting weight loss. (Adjustable gastric banding is performed laparoscopically by placing a silicone band or device around the top of the stomach to limit food intake. As weight loss is achieved, the band is tightened to maintain the effect.)

Habegger, Tschöp and team hypothesized that combining GLP-1-based drugs with adjustable gastric banding could be used to improve the efficacy of this less-invasive obesity intervention.

The team used animal models to test this hypothesis and found that treatment with a GLP-1 receptor agonist increased the weight loss associated with adjustable gastric banding and also reduced the band pressure required to achieve this weight reduction.

"Currently, surgical intervention is the best option out there for sustained weight loss," says Habegger. "One of our long-term goals at the UC Institute is to find out why these interventions work so well, and figure out ways to recreate their success in less invasive ways."

Related Stories

Gastric banding an effective long-term solution to obesity

January 17, 2013

Laparoscopic adjustable gastric banding – lap banding – is a safe and effective long-term strategy for managing obesity, according to the findings of a landmark 15-year follow-up study of patients treated in Australia.

Recommended for you

Promising progress for new treatment of type 1 diabetes

July 30, 2015

New research from Uppsala University shows promising progress in the use of anti-inflammatory cytokine for treatment of type 1 diabetes. The study, published in the open access journal Scientific Reports, reveals that administration ...

Bacteria may cause type 2 diabetes

June 1, 2015

Bacteria and viruses have an obvious role in causing infectious diseases, but microbes have also been identified as the surprising cause of other illnesses, including cervical cancer (Human papilloma virus) and stomach ulcers ...

'Crosstalk' gives clues to diabetes

June 15, 2015

Sometimes, listening in on a conversation can tell you a lot. For Mark Huising, an assistant professor in the Department of Neurobiology, Physiology and Behavior at the UC Davis College of Biological Sciences, that crosstalk ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.